Cas no for 112732-17-9,Enrofloxacin hydrochloride ACID Cas number search msds database,online free cas number chemistry search engine,cas number sigma aldrich

Post Sourcing Request Exhibition

Home > CAS No. Inquiry > 112732-17-9

[CAS Name] Enrofloxacin hydrochloride

[Formula] C19H23ClFN3O3

Search Products Post Sourcing Request

[CAS Name]Enrofloxacin hydrochloride
[Alias]1-CYCLOPROPYL-6-FLUORO-1,4-DIHYDRO-4-OXO-7-(4-ETHYL-1-PIPERAZINYL)-3-QUINOLINE CARBOXYLIC ACID; BAYTRIL; 1-Cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid hydrochloride; Enrofloxacin HCL; 1-cyclopropyl-7-(4-ethylpiperazin-1-yl)-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid; 1-cyclopropyl-7-(4-ethylpiperazin-1-yl)-6-fluoro-4-oxo-quinoline-3-carboxylic acid hydrochloride
[Number]112732-17-9
[EINECS]
[Formula]C19H23ClFN3O3
[Molecular weight]395.8556

112732-17-9 Suppliers

Company

Main Products

Zhejiang Langhua Pharmaceutical Co., Ltd.	Enrofloxacin (ENR) is a fluoroquinolone antibiotic sold by the Bayer Corporation under the trade name Baytril. Enrofloxacin is currently approved by the FDA for the treatment of individual pets and domestic animals in the United States. In September 2005, the FDA withdrew approval of Baytril for use in water to treat flocks of poultry, as this practice was noted to promote the evolution of fluoroquinolone-resistant strains of the bacterium Campylobacter, a human pathogen	Send Inquiry
Shanghai Agrotree Chemical Co., Ltd	Enrofloxacin is an antibiotic that belongs to the fluoroquinolone group, more specifically the 6-fluoro-7-piperazinyl-4-quinolones. This antibiotic is widely used in veterinary medicine as an antibacterial agent, showing high activity against both Gram-negative and Gram-positive bacteria. This compound is a chemotherapeutic, and it was first synthesized in 1983 from nalidixic acid, while the first enrofloxacin-based medicinal product was marketed in 1991 as an oral drug for poultry by Bayer under the trade name Baytril. Currently, the product is approved by the European Medicines Agency (EMA) in both injectable and tablet forms.	Send Inquiry
AH BIOPHARM CO., LTD.	It has a strong killing effect on gram-negative bacteria and a certain antibacterial effect on gram-positive bacteria and mycoplasma and has a quick effect	Send Inquiry

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us: About PharmaSources; Terms of Service; Privacy Policy; Event Data Sharing Notice; Intellectual Property; Media Partners

PharmaSources Customer Service